Thermo Fisher Scientific Inc. (NYSE:TMO) closed its $260 million deal to acquire Fermentas International Inc.
Burlington, Ont.-based Fermentas, which runs its principal operation out of Vilnius, Lithuania, makes enzymes, reagents and molecular weight markers. The company, which employs about 500 workers, posted sales of about $55 million last year.
Thermo Fisher said it integrate Fermentas into its analytical technologies division.